US House of Representatives passes bill to cap insulin price
One chamber of the United States Congress has passed a bill capping diabetes patients’ out-of-pocket insulin expenses.
by marketwire, translated by daniel pedersen
The US is one step closer to securing more affordable insulin for diabetes patients, as the House of Representatives has passed the Affordable Insulin Now Act, a bill that caps patients’ cost-sharing at USD 35 for a month’s supply of insulin.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Joe Biden hopes to end "outrageous" insulin prices
For subscribers
Biden wants to cut costs of prescription drugs in the US
For subscribers
